Lakefront Biotherapeutics | GLPG - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
argenx SE USD 4.3B 808.71M 2026-03
AstraZeneca USD 4.89B 2.67B 2026-06
Biogen USD 1.28B 2.1B 2026-06
Genmab DKK 1.5B 18M 2026-06
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 513M 189M 2026-06
Hikma Pharmaceutical USD 217M 19M 2025-12
Incyte USD 3.98B 33.45M 2026-06
Merck EUR 2.74B 415M 2026-03
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Novartis USD 7.62B 739M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
UCB EUR 1.57B 1.14B 2024-12
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06